We operate in a complex industry and amongst the many things we could focus on, Terry always puts his finger on the essential issue that really matters.
As a co-founder and general partner of Polaris Partners, Terry McGuire brings more than 25 years of successful early stage investing experience in medical and information technology companies.
Prior to starting Polaris in 1996, Terry spent 7 years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago.
As a venture capitalist, Terry has invested in 48 companies. He also co-founded three companies: Inspire Pharmaceuticals (public and sold to Merck), AIR (sold to Alkermes) and MicroCHIPS (private). Companies Terry has supported have touched more than 60 million patients and directly saved over 400,000 lives. These companies have raised over $6 billion in equity and corporate capital. As a group, they have achieved a combined peak enterprise value of over $40 billion.
In 2015, Terry was listed as one of Scientific American’s Worldview 100, visionaries who continue to reshape biotechnology and the world. In 2014, Terry was chosen to receive the Irish America Healthcare & Life Sciences 50 Award. In 2013, Terry was listed as one of Forbes’ Top Life Sciences Investors, and he received The Boston Irish Business Award. In 2011, Terry was listed in Forbes’ Midas 100 List of Top Tech Investors. He is also a recipient of the Massachusetts Society for Medical Research Award, and the Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Harvard and the City of Jerusalem. He was awarded an honorary Doctorate of Laws degree from Ohio Wesleyan University for his work in translational science.
Terry is emeritus chairman of the National Venture Capital Association (NVCA), which represents ninety percent of the venture capitalists in the United States. During his tenure as NVCA Chairman, Terry testified before Congress for Dodd-Frank Wall Street Reform and Consumer Protection Act. He is also Chairman of the Global Venture Capital Congress.
Terry chairs the board of the Thayer School of Engineering, Dartmouth College. He also sits on the boards of MIT’s The David H. Koch Institute for Integrative Cancer Research, The Arthur Rock Center for Entrepreneurship at Harvard Business School (HBS), and The Healthcare Initiative Advisory Board (HBS).
Mr. McGuire holds an MBA from Harvard Business School, an MS in engineering from The Thayer School at Dartmouth College, and a BS in physics and economics from Hobart College.
Acceleron Pharma / Adimab / Alector / Arivale / Arsenal Medical / Iora / Ironwood Pharmaceuticals / Life Line Screening / MicroCHIPS / NextCode Health / Pulmatrix / Quantum Designs / SustainX / Trevena / 480 Biomedical
Forbes Midas List
Massachusetts Society for Medical Research Award
Albert Einstein Award for Outstanding Achievement in Life Sciences
National Venture Capital Association, emeritus Board Chair
Global Venture Capital Congress, Board Chair
Thayer School of Engineering, Dartmouth College, Board Chair
Koch Institute for Integrative Cancer Research, MIT, Board Member
The Arthur Rock Center for Entrepreneurship, HBS, Board Member
Ohio Wesleyan University, honorary Doctorate of Laws
Scientific American’s Worldview 100 List
B.S., Hobart College
M.S., Thayer School Engineering, Dartmouth College
M.B.A., Harvard Business School